AI News NQ Analysis

All Cosmos Bio-Tech (ACB-KY) March 2026 Revenue NT$214 million (YoY -18.6%)

NQ Score 6/100
N1 Content Completeness 8

AI Summary (NQ-processed)

All Cosmos Bio-Tech's monthly revenue for March 2026 was NT$214 million, a decrease of 18.6% year-over-year. The company is classified in the biotechnology and medical care industry.

AI Analysis